BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38025082)

  • 61. Metabolic activation of the indoloquinazoline alkaloids evodiamine and rutaecarpine by human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
    Wen B; Roongta V; Liu L; Moore DJ
    Drug Metab Dispos; 2014 Jun; 42(6):1044-54. PubMed ID: 24696463
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New glycosidic alkaloid from the nearly ripe fruits of Euodia rutaecarpa.
    Hu CQ; Li KK; Yang XW
    J Asian Nat Prod Res; 2012; 14(7):634-9. PubMed ID: 22582827
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modulation of drug-metabolizing enzymes by extracts of a herbal medicine Evodia rutaecarpa in C57BL/6J mice.
    Ueng YF; Ko HC; Chen CF; Wang JJ; Chen KT
    Life Sci; 2002 Aug; 71(11):1267-77. PubMed ID: 12106592
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rutaecarpine administration inhibits cancer cell growth in allogenic TRAMP-C1 prostate cancer mice correlating with immune balance in vivo.
    Lin JY; Yeh TH
    Biomed Pharmacother; 2021 Jul; 139():111648. PubMed ID: 33945915
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antiproliferative Activity and Cellular Uptake of Evodiamine and Rutaecarpine Based on 3D Tumor Models.
    Guo H; Liu D; Gao B; Zhang X; You M; Ren H; Zhang H; Santos HA; Xu F
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27455219
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro relaxation of rabbit and human internal anal sphincter by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa.
    Jiang JK; Chiu JH; Yu IT; Lin JK
    Life Sci; 2000 May; 66(24):2323-35. PubMed ID: 10864095
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Preparation process of rutacarpine-hydroxypropyl-beta-cyclodextrin inclusion complex].
    Yan CL; Zhang J; Hou Y; Xue GP; Wang S; Zhao QY
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):828-32. PubMed ID: 25204173
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rutaecarpine prevents the malignant biological properties of breast cancer cells by the miR-149-3p/S100A4 axis.
    Xiong Y; Xiong C; Li P; Shan X
    Ann Transl Med; 2022 Sep; 10(17):930. PubMed ID: 36172090
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effects of rutaecarpine on the pharmacokinetics of acetaminophen in rats.
    Lee SK; Bista SR; Jeong H; Kim DH; Kang MJ; Jahng Y; Jeong TC
    Arch Pharm Res; 2007 Dec; 30(12):1629-34. PubMed ID: 18254252
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro and in vivo antiallergic effect of the fructus of Evodia rutaecarpa and its constituents.
    Shin YW; Bae EA; Cai XF; Lee JJ; Kim DH
    Biol Pharm Bull; 2007 Jan; 30(1):197-9. PubMed ID: 17202687
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Optimization of a HPLC determination method for Evodia rutaecarpa].
    Huang Z; Yi J; Wu Y; Liu Y; Chen Y; Liu Y
    Zhongguo Zhong Yao Za Zhi; 2011 Feb; 36(4):478-80. PubMed ID: 21598546
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Studies on pharmacokinetics of evodiamine and rutaecarpine in rats plasma after oral administration extracts of euodiae fructus].
    Bao T; Li Y; Weng X; Yang Q; Zhang Y; Dong Y; Zhu X
    Zhongguo Zhong Yao Za Zhi; 2011 Dec; 36(24):3519-22. PubMed ID: 22368870
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Vasorelaxing action of rutaecarpine: effects of rutaecarpine on calcium channel activities in vascular endothelial and smooth muscle cells.
    Wang GJ; Wu XC; Chen CF; Lin LC; Huang YT; Shan J; Pang PK
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1237-44. PubMed ID: 10336511
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rutaecarpine and evodiamine selected as β1-AR inhibitor candidates using β1-AR/CMC-offline-UPLC/MS prevent cardiac ischemia-reperfusion injury via energy modulation.
    Xue H; Cheng Y; Wang X; Yue Y; Zhang W; Li X
    J Pharm Biomed Anal; 2015 Nov; 115():307-14. PubMed ID: 26263059
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis of ring opening of evodiamine derivatives and evaluation on their biological activity.
    Guo W; Wang X; Zhang J; Zhang T; Lv H; Zhao C
    Chem Biol Drug Des; 2022 Apr; 99(4):535-546. PubMed ID: 34923753
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunosuppressive effects of rutaecarpine in female BALB/c mice.
    Jeon TW; Jin CH; Lee SK; Jun IH; Kim GH; Lee DJ; Jeong HG; Lee KB; Jahng Y; Jeong TC
    Toxicol Lett; 2006 Jul; 164(2):155-66. PubMed ID: 16412592
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Partial Activation and Inhibition of TRPV1 Channels by Evodiamine and Rutaecarpine, Two Major Components of the Fruits of Evodia rutaecarpa.
    Wang S; Yamamoto S; Kogure Y; Zhang W; Noguchi K; Dai Y
    J Nat Prod; 2016 May; 79(5):1225-30. PubMed ID: 27159637
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
    Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
    Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Detection and characterization of the metabolites of rutaecarpine in rats based on ultra-high-performance liquid chromatography with linear ion trap-Orbitrap mass spectrometer.
    Cai W; Guan Y; Zhou Y; Wang Y; Ji H; Liu Z
    Pharm Biol; 2017 Dec; 55(1):294-298. PubMed ID: 27927077
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Berberine Derivatives with Different Pharmacological Activities via Structural Modifications.
    Xiao D; Liu Z; Zhang S; Zhou M; He F; Zou M; Peng J; Xie X; Liu Y; Peng D
    Mini Rev Med Chem; 2018; 18(17):1424-1441. PubMed ID: 28325147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.